Key result
Elevated electromechanical activation time at admission independently predicted major cardiac adverse events in hospitalized heart failure patients (OR 1.1443; 95% CI 1.016-1.286; P=0.027).
Why the study?
This study aimed to evaluate the value of admission cardiac cycle time-corrected electromechanical activation time for predicting major cardiac adverse events in hospitalized chronic heart failure patients.
Population
145 hospitalized CHF patients with LVEF lower than 50%
Comparison
Patients with MACE vs nonMACE
Design
Prospective observational study
Follow-up
In-hospital
Authors
Loading...
May aid admission risk stratification in HF; hypothesis-generating pending prospective validation.
Observational (n=145)
Effect estimate: OR 1.1443 (95% CI 1.016-1.286)
p-value: p=0.027
Elevated EMATc measured at admission via acoustic cardiography is an independent predictor of in-hospital major adverse cardiac events in patients with chronic heart failure.
Zhang et al. (2020) conducted an observational in Chronic heart failure (n=145). Elevated electromechanical activation time (EMATc) was evaluated on Major cardiac adverse events (MACEs) including cardiogenic death, onset of acute HF, and cardiogenic shock (OR 1.1443, 95% CI 1.016-1.286, p=0.027). Elevated electromechanical activation time at admission independently predicted major cardiac adverse events in hospitalized heart failure patients (OR 1.1443; 95% CI 1.016-1.286; P=0.027).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: